lets not forget - there is interest in iPlex from big pharma - remember this? ask Gwen Ransom if Merck bioventures in Boulder still exist since she is the Manufacturing Technical Advisor - just look at her linkedin profile
. . . ."And as we announced the Merck (MRK) BioVenture in the last year or so, we continue to do acquisitions with Insmed and relationships with Insmed and Avecia for a biological standpoint to build our infrastructure and manufacturing capabilities. So I think this will be an important part of our strategy. It’s not put on the back burner as some have suggested that would take place."